Price Notifications

S.No
      Date      
S.O.No.
Formulation based on bulk drugs / Brand
Name of the Schedule Formulation
Strength
Attachment
1
29-03-2019
1489 (E)
NPPA has fixed retail prices of 21 formulations under Drugs (Prices Control) Order, 2013
Formulations specified in the corresponding entry in column (2) of the Table in the Notification
strength as specified in the corresponding entries in columns (3) of the Table in the Notification
2
29-03-2019
1488 (E)
NPPA has revised ceiling prices of coronary stent under Drugs (Prices Control) Order, 2013
Formulations specified in the corresponding entry in column (2) of the Table in the Notification
strength as specified in the corresponding entries in columns (3) of the Table in the Notification
3
29-03-2019
1487 (E)
NPPA has revised ceiling pricess of 8 formulations under Drugs (Prices Control) Order, 2013
Formulations specified in the corresponding entry in column (2) of the Table in the Notification
strength as specified in the corresponding entries in columns (3) of the Table in the Notification
4
29-03-2019
1486 (E)
NPPA has revised ceiling prices of 16 formulations under Drugs (Prices Control) Order, 2013
Formulations specified in the corresponding entry in column (2) of the Table in the Notification
strength as specified in the corresponding entries in columns (3) of the Table in the Notification
5
29-03-2019
1485 (E)
NPPA has revised ceiling prices of 847 formulations under Drugs (Prices Control) Order, 2013
Formulations specified in the corresponding entry in column (2) of the Table in the Notification
strength as specified in the corresponding entries in columns (3) of the Table in the Notification
6
19-03-2019
1395 (E)
NPPA has fixed retail prices of 2 formulations under Drugs (Prices Control) Order, 2013
Formulations specified in the corresponding entry in column (2) of the Table in the Notification
strength as specified in the corresponding entries in columns (3) of the Table in the Notification
7
27-02-2019
1041 (E)
Retail Price of 42 non-scheduled Anti-Cancer Drugs
Formulations specified in the Table B of the Order
Whether individual or in combination, irrespective of dosage strength, dosage form and /or route of administration
8
26-02-2019
1030 (E)
NPPA has fixed the retail price 21 formulations under Drugs Price (Control) Order,2013.
Formulations specified in the corresponding entry in column (2) of the Table in the Notification
strength as specified in the corresponding entries in columns (3) of the Table in the Notification
9
26-02-2019
1029 (E)
NPPA has fixed Retail prices of 01 formulation under (Prices Control) Order,2013.
Formulations specified in the corresponding entry in column (2) of the Table in the Notification
strength as specified in the corresponding entries in columns (3) of the Table in the Notification
10
26-02-2019
1028 (E)
NPPA has fixed/revised Ceiling prices of 14 scheduled formulations under (Prices Control) Order,2013.
Formulations specified in the corresponding entry in column (2) of the Table in the Notification
strength as specified in the corresponding entries in columns (3) of the Table in the Notification
11
05-02-2019
703 (E)
NPPA has fixed the retail price of 1(one) formulation under Drugs Price (Control) Order, 2013
Formulations specified in the corresponding entry in column (2) of the Table in the Notification
strength as specified in the corresponding entries in columns (3) of the Table in the Notification
12
25-01-2019
452 (E)
Retail prices of 29 Formulations under Para 5 of DPCO 2013
Formulations specified in the corresponding entry in column (2) of the Table in the Notification
strength as specified in the corresponding entries in columns (3) of the Table in the Notification
© 2017 All Rights Reserved | Promoted By: Tyche Medisales Pvt. Ltd. | Designed & Maintained By: Extrem Web About Us Privacy Policy Disclaimer Terms & Conditions HyperLink Policy Copyright Contact Us